✦ LIBER ✦

Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results

✍ Scribed by F. LEONI; S. CIOIXI; G. GIULIANI; A. PASCARELLA; R. CAPORALE; F. SALTI; L. CERVI; P. Rossi FERRINI

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of conventional-dose cytosine ar

✍ A. Heyll; C. Aul; F. Gogolin; V. Runde; D. Söhngen; G. Meckenstock; H. -H. Wolf; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 549 KB

The use of an all oral chemotherapy (ida

✍ Jackson, G H; Taylor, P R A; Iqbal, A; Galloway, M J; Turner, G; Haynes, A; Hami 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 197 KB

Oral treatment of acute myeloid leukaemi

✍ T. Ruutu; E. Koivunen; T. Nousiainen; T.-T. Pelliniemi; A. Almqvist; P. Anttila; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

The selective use of AMSA following high

✍ Richard A. Larson; Roger S. Day; Nozar Azarnia; John M. Bennett; George Browman; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

Adding low-dose gemtuzumab ozogamicin to

✍ Marino Clavio; Luana Vignolo; Alessandra Albarello; Riccardo Varaldo; Ivana Pier 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

The impact of dose escalation and resist

✍ Alan K. Burnett; Donald Milligan; Anthony Goldstone; Archibald Prentice; Mary-Fr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB